Skip to content
logo-orbit-white
Main Menu
  • Training Courses
    • RRI Training
    • Trusted Research
    • Design of Ethical AI Systems
    • Stakeholder Engagement
    • Data Governance
    • Ethical Hackathons
    • Responsible Quantum Technologies
    • Environmentally Sustainable Research
  • Resources & Tools
    • AREA 4P Framework
    • The Keys of RRI
    • About RRI Maturity
    • Self Assessment Tool
    • Self Assessment Results
    • RRI Maturity
    • RRI Maturity Results
    • Action Plan
    • Action Plan Results
  • Services
  • News
  • Contact
Login

RRI Training

I

Trusted Research Training

I

Ethical AI Systems Training

I

Stakeholder Engagement

I

Data Governance

I

Sustainable Research

  • About ORBIT
    • AREA 4P Framework
    • The Keys of RRI
    • Employment Opportunities
  • Tools
  • Contact
  • Account
    • Workshop Hub
    • Your Courses
    • Organisation RRI Maturity Archive
    • RRI Intensity Level Archive
    • Your Action Plans
    • Delete Your Account
  • Embrace Course Booking
  • Journal
  • Toggle website search
Read more about the article China Approves Commercial Brain Chips, Outpacing Western Trials

China Approves Commercial Brain Chips, Outpacing Western Trials

The National Medical Products Administration of China has granted approval for the sale of the country's first commercial brain chips, allowing direct sales to patients. This significant development positions China…

Read more about the article Celebrating Kiran Mazumdar-Shaw: A Pioneer in Biotechnology

Celebrating Kiran Mazumdar-Shaw: A Pioneer in Biotechnology

Kiran Mazumdar-Shaw, born on 23 March 1953, stands as a pioneering figure in India's biotechnology sector and is recognised as one of the nation's most influential business leaders. As the…

Read more about the article Novartis to Acquire Promising Breast Cancer Drug in Up to $3 Billion Agreement

Novartis to Acquire Promising Breast Cancer Drug in Up to $3 Billion Agreement

Swiss pharmaceutical company Novartis has announced an agreement to acquire a breast cancer drug candidate from U.S. biotech firm Synnovation Therapeutics for a total of up to $3 billion. This…

Read more about the article Cathy Tie Establishes Origin Genomics to Promote Responsible Germline Gene Correction in the United States

Cathy Tie Establishes Origin Genomics to Promote Responsible Germline Gene Correction in the United States

NEW YORK--(BUSINESS WIRE)--Cathy Tie, a serial entrepreneur in the biotech sector, has officially announced the founding of Origin Genomics, a company located in New York aimed at enhancing precision in…

Read more about the article Greenland Mines Partners with WSP Denmark to Implement Environmental Baseline Program at Skaergaard Mining Project

Greenland Mines Partners with WSP Denmark to Implement Environmental Baseline Program at Skaergaard Mining Project

Engagement promotes the pathway to exploitation license while fostering responsible, large-scale development of the Skaergaard Project. CHARLOTTE, N.C., March 19, 2026 /PRNewswire/ -- Greenland Mines Ltd ("Greenland Mines" or the…

Read more about the article Significant Growth in India’s Bioeconomy: Insights from Dr Jitendra Singh

Significant Growth in India’s Bioeconomy: Insights from Dr Jitendra Singh

New Delhi, March 19 (IANS) – Union Minister Dr Jitendra Singh recently announced that India’s bioeconomy has experienced remarkable expansion, reaching over $195 billion in 2025, a substantial increase from…

Read more about the article Hanskin Expands U.S. Presence with Launch in 1,400 ULTA Beauty Stores

Hanskin Expands U.S. Presence with Launch in 1,400 ULTA Beauty Stores

Hanskin, a prominent name in K-Beauty skincare, is set to enhance its footprint in North America with the introduction of its products in approximately 1,400 ULTA Beauty locations across the…

Read more about the article Causeway Therapeutics Unveils Promising Phase 2 Clinical Trial Results for TenoMiR® in Lateral Epicondylitis

Causeway Therapeutics Unveils Promising Phase 2 Clinical Trial Results for TenoMiR® in Lateral Epicondylitis

GLASGOW, Scotland, March 19, 2026 (GLOBE NEWSWIRE) – Causeway Therapeutics, a clinical-stage biotechnology company focused on pioneering treatments for tendon diseases, has announced the presentation of data from its Phase…

Read more about the article Scinai Immunotherapeutics Showcases Enhanced CDMO Capabilities and Immunology Pipeline at BIO-Europe Spring® 2026

Scinai Immunotherapeutics Showcases Enhanced CDMO Capabilities and Immunology Pipeline at BIO-Europe Spring® 2026

March 19, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical enterprise dedicated to advancing innovative therapeutics in inflammation and immunology, alongside its subsidiary Scinai Biopharma Services Ltd., a…

Read more about the article Green Elephant Biotech Launches Archimedes® One: A New Era in Cell Therapy Manufacturing

Green Elephant Biotech Launches Archimedes® One: A New Era in Cell Therapy Manufacturing

Giessen, Germany – 17 March 2026 – Green Elephant Biotech has announced the market introduction of Archimedes® One, pioneering a new category known as the Dynamic Adherent Bioreactor. This innovative…

  • Go to the previous page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 14
  • Go to the next page

Course Information

Help & Information

  • About ORBIT
  • Terms & Conditions
  • Privacy Policy
  • Data Breach Policy
  • Contact
  • About ORBIT
  • Terms & Conditions
  • Privacy Policy
  • Data Breach Policy
  • Contact

Contact Us

  • contact@orbit-rri.org
  • @orbitrri
  • @orbitrri

Training & Workshops

AI Empowerment

Stakeholder Engagement

Trusted Research

Data Governance

Ethical Hackathons

RRI Training

Responsible Quantum Technologies

Environmentally Sustainable Research

Design of Ethical AI Systems

  • About ORBIT
  • Terms & Conditions
  • Privacy Policy
  • Data Breach Policy
  • Contact
Copyright 2023 - ORBIT RRI a not for profit company.

By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.

Accept